RxDoctor Payments Data

Wairimu Mwaura

Family · Murrieta, CANPI 1598320996

Payments from drug & device makers

$10,071in general payments, 2019–2025

Across 329 payments — averaging $30.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AstraZeneca$964
  • GSK$484
  • Novartis$459
  • Bristol Myers Squibb$445
  • Merck$441
  • plus $6K from 53 others

What the payments were for

  • Food & beverage$8,94489%
  • Education$1,12811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson26$1,211
AstraZeneca(2 entities)29$964
GSK8$484
Novartis21$459
Bristol Myers Squibb22$445
Merck17$441
Incyte Corporation9$431
Pfizer21$420
Daiichi Sankyo Inc.10$415
Sobi, Inc12$392
Pharmacyclics LLC, An Abbvie Company9$282
Regeneron Healthcare Solutions, Inc.6$246
Astellas Pharma US Inc4$244
AbbVie11$234
Stemline Therapeutics Inc.3$204
Takeda Pharmaceuticals U.S.A., Inc.6$188
Gilead(2 entities)3$175
Bayer8$171
Coherus Oncology, Inc.9$171
Sanofi6$169
Beigene USA, Inc.6$155
Eisai Inc.2$148
Lilly USA, LLC8$148
Array Biopharma Inc6$133
AVEO Pharmaceuticals, Inc.2$121
Exelixis Inc.5$114
E.r. Squibb & Sons, L.L.C.2$112
Pharmaessentia USA Corporation3$99
Amgen4$96
Blueprint Medicines Corporation4$89
Taiho Oncology, Inc.3$86
Iovance Biotherapeutics, Inc.4$75
Ipsen Biopharmaceuticals, Inc3$71
Rigel Pharmaceuticals, Inc.2$68
Genentech USA, Inc.2$54
Agios Pharmaceuticals, Inc.2$53
Verity Pharmaceuticals Inc.2$51
Karyopharm Therapeutics Inc.2$49
Caris MPI, Inc.2$47
Jazz Pharmaceuticals Inc.2$45
Accord Healthcare, Inc.2$44
Azurity Pharmaceuticals, Inc.2$42
Seagen Inc.1$40
Puma Biotechnology, Inc.2$39
Legend Biotech USA Inc.1$33
Pharmacosmos Therapeutics Inc.2$32
Syndax Pharmaceuticals, Inc.1$29
Mirati Therapeutics, Inc.1$28
Geron Corporation1$26
Spectrum Pharmaceuticals Inc.1$26
Tempus AI, Inc1$26
Acceleron Pharma, Inc.1$24
Tersera Therapeutics LLC1$23
Morphosys, US Inc.1$22
Recordati_rare_diseases_inc.1$18
Fresenius Kabi USA, LLC1$18
Fennec Pharmaceuticals, Inc.1$18
Boehringer Ingelheim1$16
Athena Bioscience, LLC1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,071 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Medicare billing

Part B allowed, 2024
$2,235
Medicare patients
22
Services billed
27

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron79$751
Prochlorperazine Maleate86$732
Dexamethasone18$204
Omeprazole13$117
Lorazepam14$65
Levofloxacin11$41
Prednisone17$37

Paid to pharmacies, not to this prescriber.

Other family in Murrieta

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →